As T cells recognize specific parts of antigens (epitopes), MHC-tumour-derived peptide complexes often carry a small portion of amino acids corresponding to T-cell epitopes and thus enhance their affinity profile [58]. The gene discussed is HLA-C; the disease is neoplasm.